骨痛灵酊对腰椎间盘突出症患者血清5-HT和β-EP水平的影响

摘要/Abstract

摘要： 目的探讨与分析骨痛灵酊对腰椎间盘突出症患者血清5-羟色胺（5-hydmzytryptamine,5-HT）和β-内啡肽（β- Endorphins,β-EP）水平的影响。方法选择2019年4月—2023年1月在新疆生产建设兵团医院城北分院诊治的120例腰椎间盘突出症患者作为研究对象,根据1:1随机抽签法把120例患者分为骨痛灵酊组60例与对照组60例。对照组给予常规药物治疗,骨痛灵酊组在对照组治疗的基础上给予骨痛灵酊治疗,连续治疗观察8周,检测两组患者血清5-羟色胺和β-内啡肽水平变化情况,判定临床疗效、腰屈曲范围与疼痛MPQ评分变化情况。结果治疗8周后骨痛灵酊组的疗效优良率显著高于对照组,差异有统计学意义（P<0.05）。两组治疗8周后的疼痛MPQ评分都明显低于治疗前,差异有统计学意义（P<0.05）,骨痛灵酊组治疗8周后的疼痛MPQ评分与对照组相比明显降低,差异有统计学意义（P<0.05）。两组治疗8周后的腰屈曲范围都明显高于治疗前,差异有统计学意义（P<0.05）,骨痛灵酊组治疗8周后的腰屈曲范围与对照组相比明显升高,差异有统计学意义（P<0.05）。两组治疗8周后的血清5-羟色胺、β-内啡肽含量低于治疗前,差异有统计学意义（P<0.05）,骨痛灵酊组治疗8周后血清5-羟色胺、β-内啡肽含量与对照组相比也显著降低,差异有统计学意义（P<0.05）。结论骨痛灵酊在腰椎间盘突出症患者中的应用能抑制血清5-羟色胺、β-内啡肽的表达,能促进缓解疼痛,提高患者的总体治疗效果,还可改善患者的腰屈曲范围。

关键词: 骨痛灵酊, 腰椎间盘突出症, 5-羟色胺, β-内啡肽, 腰屈曲范围

Abstract: Objective To explore and analysis the effects of Gutongling tincture on serum 5-hydroxytryptamine (5-HT) and β-Endorphins(β-EP) leveles in the Lumbar disc herniation patients. Methods From April 2019 to January 2023, 120 cases of patients with lumbar disc herniation diagnosed and treated in Xinjiang Production and Construction Corps Hospital, Chengbei Branch were selected as the study subjects, and the 120 patients were divided into the Gutongling tincture group of 60 cases and the control group of 60 cases accorded to the 1:1 random drawing method. The control group were treated with conventional drugs, while the Gutongling tincture group were treated with Gutongling tincture on the basis of the control group's treatment. Continuous treatment observation were conducted for eight weeks in the two groups, and serum 5-HT and β-EP levels were detected in both groups of patients, observed the clinical efficacy, the changes of range of lumbar flexion and pain MPQ score. Results After eight weeks of treatment, the excellent and good efficacy rate of the Gutongling tincture group were significantly higher than the control group (P<0.05). The pain MPQ scores of both groups after eight weeks of treatment were significantly lower than before treatment (P<0.05), while the pain MPQ scores of the Gutongling tincture group after eight weeks of treatment were significantly lower than those of the control group (P<0.05). After eight weeks of treatment, the range of lumbar flexion in both groups were significantly higher than before treatment (P<0.05), and the range of lumbar flexion in the Gutongling tincture group were significantly higher than that in the control group after eight weeks of treatment (P<0.05). The serum 5-HT and β-EP levels after eight weeks of treatment in two groups were lower than that before treatment (P<0.05), and the serum 5-HT and β-EP levels in the Gutongling tincture group were also decreased significantly compared with the control group (P<0.05). Conclusion The application of Gutongling tincture in patients with lumbar disc herniation can inhibit serum expression of 5-HT and β-EP, it can promote pain relief, improve the overall therapeutic effect of patients, and also improve the range of lumbar flexion of patients.

Key words: Gutongling tincture, lumbar disc herniation, 5-hydroxytryptamine, β- endorphins, lumbar flexion range

中图分类号:

R274.9

张慧慧, 李波. 骨痛灵酊对腰椎间盘突出症患者血清5-HT和β-EP水平的影响[J]. 中华养生保健, 2024, 42(11): 26-29.

ZHANG Hui-hui, LI Bo. Effect of Gutongling Tincture on Serum 5-HT and β-EP Level in the Lumbar Disc Herniation Patients[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(11): 26-29.

参考文献

[1] 杨德龙,赵继荣,陈文,等.熥敷颈腰痛贴治疗腰椎间盘突出症临床研究[J].河南中医,2023,43(3):424-427.
[2] 林依怀,王史潮,吕存贤.腰椎定点旋转复位手法联合如意金黄膏外敷治疗腰椎间盘突出症的临床观察[J].中国中医药科技,2022,29(3):431-432.
[3] 尹燊,袁玉梅,吴昊达.针刺联合乌麻膏外敷治疗腰椎间盘突出症的临床观察[J].广州中医药大学学报,2022,39(9):2059-2065.
[4] 伊伟恩,邓建军,郑小锋,等.活血通络汤治疗腰椎间盘突出症(血瘀证)疗效及对患者血液流变学和IL-1β、IL-6、TNF-α的影响[J].四川中医,2022,40(7):120-123.
[5] 潘名望,张建强.加减和营止痛汤联合循经点揉推拿法治疗腰椎间盘突出症的疗效观察[J].中国中医药科技,2022,29(6):1016-1018.
[6] 赵明成,张玉民,翟迎敏,等.筋展络通胶囊口服联合骨科洗剂外敷配合腰椎牵引治疗急性腰椎间盘突出症[J].颈腰痛杂志,2021,42(3):429-431.
[7] 袁海升,李国帅,薛勇,等.何氏骨科对腰椎间盘突出症的中医认识及治疗特色[J].四川中医,2021,39(1):29-31.
[8] 丁江浩,江文星,林智玲.督脉雷火灸治疗腰椎间盘突出症临床研究[J].湖北中医药大学学报,2021,23(1):86-88.
[9] 中华医学会骨科学分会脊柱外科学组,中华医学会骨科学分会骨科康复学组.腰椎间盘突出症诊疗指南[J].中华骨科杂志,2020,40(8):477-487.
[10] 国家中医药管理局.中医病症诊断疗效标准[M].北京:中国医药科技出版社,2012:214.
[11] 李剑,祝天经.腰椎间盘突出症的疗效评定标准与康复标准[J].现代康复,2001,5(14):15-16.
[12] 张磊,贺石生.脊髓损伤后疼痛评估系统的使用及选择比较[J].中国康复医学杂志,2014,29(4):360-363.
[13] 汲传波,郭彦军,孟庆刚,等.中药外敷加推拿手法治疗腰椎间盘突出症疗效观察[J].人民军医,2021,64(10):999-1000,1008.
[14] 沈向楠,李革飞,王鹏,等.放散式冲击波联合中药外敷治疗腰椎间盘突出症椎间孔镜术后残余腰骶部疼痛46例[J].中国中医骨伤科杂志,2020,28(5):48-50.
[15] 牟成林,沈向楠,李革飞,等.中医正骨手法联合中药外敷改善腰椎间盘突出症腰椎曲度的疗效观察[J].时珍国医国药,2020,31(5):1179-1183.
[16] 甄朋超,王庆甫,赵环宇,等.吴氏手法配合宣痹膏治疗腰椎间盘突出症急性期机制初探[J].中国中医急症,2020,29(8):1403-1406,1410.
[17] 刘会洋,张鹏,杨俊勇,等.电针夹脊穴联合散寒活血止痛方中药外敷治疗腰椎间盘突出症的疗效及对凝血功能、血小板的影响[J].血栓与止血学,2020,26(5):756-758.
[18] 刘刚刚,孙钰,耿君.导气督穴针法合中药外敷治疗腰椎间盘突出症血瘀证疗效及对炎性因子、VEGF水平的影响[J].现代中西医结合杂志,2019,28(31):3450-3453,3511.
[19] 毛友兵,王青松,史朝红,等.电针疗法联合中药外敷治疗腰椎间盘突出症的疗效观察[J].中国中医急症,2019,28(5):892-895.
[20] 陈婷婷,曾宪敏,李安洪.推拿联合针灸治疗腰椎间盘突出症的疗效及对相关炎性因子影响的临床研究[J].贵阳中医学院学报,2019,41(1):36-41,46.